Mouthrinse active matrix metalloproteinase-8 in periodontitis prevention
- 22 June 2026
- journal article
- Published by Elsevier in The Journal of the American Dental Association
Abstract
No abstract availableFunding Information
- Helsingin ja Uudenmaan Sairaanhoitopiiri (Y2519SU010)
- Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH2020337)
- Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH2022225)
- Suomen Hammaslääkäriliitto
- Suomen Hammaslääkäriseura Apollonia
- Karolinska Institutet
This publication has 6 references indexed in Scilit:
- Matrix Metalloproteinases in Periodontal and Peri‐Implant Diseases: Contribution to Their Pathogenesis, Diagnosis, and TreatmentJournal of Periodontal Research, 2026
- aMMP‐8 self‐testing and self‐administered questionnaires for periodontitis screening: A diagnostic trial in a Chinese populationJournal of Periodontology, 2025
- Reply to Markaryan et al. Comment on “Aji et al. aMMP-8 POCT vs. Other Potential Biomarkers in Chair-Side Diagnostics and Treatment Monitoring of Severe Periodontitis. Int. J. Mol. Sci. 2024, 25, 9421”International Journal of Molecular Sciences, 2025
- aMMP-8 and MMP-9: Potential Biomarkers for periodontitis Progression in Patients Receiving Radiotherapy for Head and Neck CarcinomaCancer Control, 2025
- A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with PeriodontitisDiagnostics, 2023
- Periodontal diseasesNature Reviews Disease Primers, 2017